دورية أكاديمية
Small molecule inhibits alpha-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
| العنوان: | Small molecule inhibits alpha-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons |
|---|---|
| المؤلفون: | Pujols, J., Pena-Diaz, S., Lazaro, D.F., Peccati, F., Pinheiro, F., Gonzalez, D., Carija, A., Navarro, S., Conde-Gimenez, M., Garcia, J., Guardiola, S., Giralt, E., Salvatella, X., Sancho, J., Sodupe, M., Outeiro, T.F., Dalfo, E., Ventura, S. |
| سنة النشر: | 2018 |
| المجموعة: | Digital Repository of University of Zaragoza (ZAGUAN) |
| الوصف: | Parkinson''s disease (PD) is characterized by a progressive loss of dopaminergic neurons, a process that current therapeutic approaches cannot prevent. In PD, the typical pathological hallmark is the accumulation of intracellular protein inclusions, known as Lewy bodies and Lewy neurites, which are mainly composed of alpha-synuclein. Here, we exploited a high-throughput screening methodology to identify a small molecule (SynuClean-D) able to inhibit alpha-synuclein aggregation. SynuClean-D significantly reduces the in vitro aggregation of wildtype alpha-synuclein and the familiar A30P and H50Q variants in a substoichiometric molar ratio. This compound prevents fibril propagation in protein-misfolding cyclic amplification assays and decreases the number of alpha-synuclein inclusions in human neuroglioma cells. Computational analysis suggests that SynuClean-D can bind to cavities in mature alpha-synuclein fibrils and, indeed, it displays a strong fibril disaggregation activity. The treatment with SynuClean-D of two PD Caenorhabditis elegans models, expressing alpha-synuclein either in muscle or in dopaminergic neurons, significantly reduces the toxicity exerted by alpha- synuclein. SynuClean-D-treated worms show decreased alpha-synuclein aggregation in muscle and a concomitant motility recovery. More importantly, this compound is able to rescue dopaminergic neurons from alpha-synuclein-induced degeneration. Overall, SynuClean-D appears to be a promising molecule for therapeutic intervention in Parkinson's disease. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | info:eu-repo/grantAgreement/ES/DGA/E45-17R; info:eu-repo/grantAgreement/ES/MINECO/BFU2016-78232-P; http://zaguan.unizar.es/record/75810Test |
| DOI: | 10.1073/pnas.1804198115 |
| الإتاحة: | https://doi.org/10.1073/pnas.1804198115Test http://zaguan.unizar.es/record/75810Test |
| حقوق: | All rights reserved ; http://www.europeana.eu/rights/rr-fTest/ |
| رقم الانضمام: | edsbas.F0EDF82C |
| قاعدة البيانات: | BASE |
| DOI: | 10.1073/pnas.1804198115 |
|---|